In ccRCC, overexpression of PCK1 can suppress tumor progression via inhibition of lactate dehydrogenase A (LDHA), and patients with high PCK1 expression had better prognosis [8]. The gene discussed is PCK1; the disease is nonpapillary renal cell carcinoma.